Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Nobutake Tanaka is active.

Publication


Featured researches published by Nobutake Tanaka.


Scientific Reports | 2018

Clinical Implications of Lysyl Oxidase-Like Protein 2 Expression in Pancreatic Cancer

Nobutake Tanaka; Suguru Yamada; Fuminori Sonohara; Masaya Suenaga; Masamichi Hayashi; Hideki Takami; Yukiko Niwa; Norifumi Hattori; Naoki Iwata; Mitsuro Kanda; Chie Tanaka; Daisuke Kobayashi; Goro Nakayama; Masahiko Koike; Michitaka Fujiwara; Tsutomu Fujii; Yasuhiro Kodera

Lysyl oxidase (LOX) family genes, particularly lysyl oxidase-like protein 2 (LOXL2), have been implicated in carcinogenesis, metastasis, and the epithelial-to-mesenchymal transition (EMT) in various cancers. This study aimed to explore the clinical implications of LOXL2 expression in pancreatic cancer (PC) in the context of EMT status. LOX family mRNA expression was measured in PC cell lines, and LOXL2 protein levels were examined in surgical specimens resected from 170 patients with PC. Higher LOXL2 expression was observed in cell lines from mesenchymal type PC than in those from epithelial type PC. A significant correlation between LOXL2 expression and the EMT status defined based on the expression of E-cadherin and vimentin was observed in surgical specimens (P < 0.01). The disease-free survival and overall survival rates among patients with low LOXL2 expression were significantly better than those among patients with high LOXL2 expression (P < 0.001). According to the multivariate analysis, high LOXL2 expression (P = 0.03) was a significant independent prognostic factor for patients with PC. Additionally, LOX inhibition significantly decreased PC cell proliferation, migration, and invasion in vitro. In conclusion, LOXL2 expression is potentially associated with PC progression, and LOXL2 expression represents a biomarker for predicting the prognosis of patients with PC who have undergone complete resection.


Annals of Gastroenterological Surgery | 2018

Perioperative and prognostic implication of albumin-bilirubin-TNM score in Child-Pugh class A hepatocellular carcinoma

Fuminori Sonohara; Suguru Yamada; Nobutake Tanaka; Masaya Suenaga; Hideki Takami; Masamichi Hayashi; Yukiko Niwa; Hiroyuki Sugimoto; Norifumi Hattori; Mitsuro Kanda; Chie Tanaka; Daisuke Kobayashi; Goro Nakayama; Masahiko Koike; Michitaka Fujiwara; Yasuhiro Kodera

A reliable classification for predicting postoperative prognosis and perioperative risk of hepatocellular carcinoma (HCC) patients is required to make a precise decision for HCC treatment. In the present study, we assessed the perioperative and prognostic importance of indocyanine green (ICG) testing, tumor‐node‐metastasis (TNM) stage, albumin‐bilirubin (ALBI) grade, and ALBI‐TNM (ALBI‐T) score using consecutive resected HCC cases.


Gastric Cancer | 2015

A feasibility study of postoperative chemotherapy with S-1 and cisplatin (CDDP) for stage III/IV gastric cancer (CCOG 1106)

Keisuke Kurimoto; Kiyoshi Ishigure; Yoshinari Mochizuki; Akiharu Ishiyama; Takanori Matsui; Seiji Ito; Hiroshi Nakayama; Nobutake Tanaka; Daisuke Kobayashi; Junichi Sakamoto; Akimasa Nakao; Yasuhiro Kodera


Journal of Clinical Oncology | 2014

Clinical benefits of bevacizumab in metastatic colorectal cancer depending on KRAS status.

Keisuke Kurimoto; Kiyoshi Ishigure; Yoshiyasu Kato; Yasuyuki Asai; Nobutake Tanaka; Song Ryo; Hidenobu Matsushita; Junichi Tobinaga; Ryuichi Fukuyama; Hiruhumi Kuroda; Tomoo Fujii


Hpb | 2018

Predictive factors for portal and splenic vein thrombosis after distal pancreatectomy

Nobutake Tanaka; Suguru Yamada; Hideki Takami; Masaya Suenaga; Masamichi Hayashi; Yukiko Niwa; Yasuhiro Kodera


Hpb | 2018

Inverse probability of treatment weighting analysis of upfront surgery versus neoadjuvant chemoradiotherapy followed by surgery for pancreatic adenocarcinoma with arterial abutment

Tsutomu Fujii; Suguru Yamada; Kenta Murotani; Hideki Takami; Nobutake Tanaka; Isaku Yoshioka; Kazuto Shibuya; T. Okumura; Yasuhiro Kodera


The Japanese Journal of Gastroenterological Surgery | 2017

Tumor-Forming Autoimmune Pancreatitis Confused with Pancreatic Cancer That Developed during the Course of Chronic Pancreatitis

Nobutake Tanaka; Tsutomu Fujii; Suguru Yamada; Hideki Takami; Masamichi Hayashi; Daishi Morimoto; Mitsuru Tashiro; Hiroyuki Sugimoto; Yasuhiro Kodera


The Japanese Journal of Gastroenterological Surgery | 2017

Usefulness of Intraoperative Angiography in a Hybrid Operating Room for Pancreaticoduodenectomy in Patients with Celiac Axis Stenosis: Report of Two Cases

Daishi Morimoto; Tsutomu Fujii; Suguru Yamada; Kojiro Suzuki; Hideki Takami; Mitsuru Tashiro; Nobutake Tanaka; Masamichi Hayashi; Hiroyuki Sugimoto; Yasuhiro Kodera


The Japanese Journal of Gastroenterological Surgery | 2017

Splenic Aneurysm Near the Origin of Splenic Artery and Splenic Hamartoma with Stricture of the Celiac Artery Due to Median Arcuate Ligament Compression

Mitsuru Tashiro; Tsutomu Fujii; Suguru Yamada; Kojiro Suzuki; Daishi Morimoto; Nobutake Tanaka; Hideki Takami; Masamichi Hayashi; Hiroyuki Sugimoto; Yasuhiro Kodera


Pancreatology | 2017

Analysis of predictive factors for portal and splenic vein thrombosis after distal pancreatectomy

Nobutake Tanaka; Tsutomu Fujii; Suguru Yamada; Daishi Morimoto; Hideki Takami; Masamichi Hayashi; Hiroyuki Sugimoto; Yasuhiro Kodera

Collaboration


Dive into the Nobutake Tanaka's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge